We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$9.41B
AUM Growth
+$892M
Cap. Flow
+$716M
Cap. Flow %
7.61%
Top 10 Hldgs %
12.32%
Holding
577
New
120
Increased
118
Reduced
120
Closed
208

Top Buys

Rank Stock Value
1
HPE icon
Hewlett Packard
HPE
+$131M
2
SYF icon
Synchrony
SYF
+$120M
3
CELG
Celgene Corp
CELG
+$105M
4
VMW
VMware, Inc
VMW
+$104M
5
ESRX
Express Scripts Holding Company
ESRX
+$90.6M

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$112M
2
CTSH icon
Cognizant
CTSH
+$100M
3
WDC icon
Western Digital
WDC
+$98.6M
4
MSFT icon
Microsoft
MSFT
+$92M
5
SIAL
SIGMA - ALDRICH CORP
SIAL
+$84M

Sector Composition

Rank Sector Weight
1 Industrials 17.29%
2 Technology 14.74%
3 Healthcare 14.44%
4 Financials 13.07%
5 Energy 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLRX
351
BioLineRX
BLRX
$11.8M
$578K 0.01%
741
-578
-44% -$480K
FATE icon
352
Fate Therapeutics
FATE
$326M
$569K 0.01%
168,881
-10,505
-6% -$44.2K
TTHI
353
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
$544K 0.01%
283,315
+11,551
+4% +$21.9K
ARGS
354
DELISTED
Argos Therapeutics, Inc.
ARGS
$467K 0.01%
10,107
+2,906
+40% +$246K
NTBL
355
CALL
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$438K ﹤0.01%
+2,381
New +$502K
KALV
356
DELISTED
KalVista Pharmaceuticals
KALV
$415K ﹤0.01%
8,186
+383
+5% +$20K
BLPH
357
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$413K ﹤0.01%
9,302
+537
+6% +$26K
ALPN
358
DELISTED
Alpine Immune Sciences Inc
ALPN
$392K ﹤0.01%
12,669
+417
+3% +$14.2K
HTGM
359
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$391K ﹤0.01%
498
-136
-21% -$134K
DTEA
360
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$329K ﹤0.01%
26,562
-13,438
-34% -$183K
BIND
361
CALL
DELISTED
BIND THERAPEUTICS INC
BIND
$263K ﹤0.01%
114,786
– –
PLXP
362
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$252K ﹤0.01%
2,813
-10,947
-80% -$1.05M
MBII
363
DELISTED
Marrone Bio Innovations, Inc.
MBII
$169K ﹤0.01%
153,308
-44,573
-23% -$95.5K
ADMA icon
364
ADMA Biologics
ADMA
$2.22B
$130K ﹤0.01%
16,077
-39,866
-71% -$359K
RLJE
365
CALL
DELISTED
RLJ Entertainment, Inc.
RLJE
$116K ﹤0.01%
66,667
– –
TCPI
366
DELISTED
TCP International Hldgs Ltd.
TCPI
$63K ﹤0.01%
65,577
-87,710
-57% -$143K
GEVO icon
367
CALL
Gevo
GEVO
$382M
$60K ﹤0.01%
243
– –
EVAR
368
DELISTED
Lombard Medical, Inc.
EVAR
$55K ﹤0.01%
40,374
-126,630
-76% -$299K
ADAP
369
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-118,419
Closed -$1.42M
AIG icon
370
American International
AIG
$41.3B
– –
-285,000
Closed -$16.2M
AL
371
DELISTED
Air Lease Corp
AL
– –
-507,586
Closed -$15.7M
ALLY icon
372
Ally Financial
ALLY
$13.3B
– –
-1,483,822
Closed -$30.2M
ALRM icon
373
Alarm.com
ALRM
$2.85B
– –
-51,736
Closed -$603K
AMG icon
374
Affiliated Managers Group
AMG
$9.76B
– –
-17,377
Closed -$2.97M
ARCC icon
375
Ares Capital
ARCC
$14.4B
– –
-207,023
Closed -$3M
13 14
15
16 17

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q4 2015 Portfolio in Review

As of Q4 2015, Alyeska Investment Group held 577 positions worth $9.41B, up 10% from $8.52B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Alyeska Investment Group deployed $716M of net new capital in Q4 2015, opening 120 new positions and adding to 118 existing holdings. Its largest new stake was Hewlett Packard: 15,626,018 shares worth $138M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Bankunited, an estimated $43.3M trimmed.

  • Alyeska Investment Group's largest Q4 2015 buy was Hewlett Packard: 15,626,018 shares worth $138M.
  • Alyeska Investment Group added most to Synchrony in Q4 2015, an estimated $120M increase.
  • Alyeska Investment Group's biggest Q4 2015 reduction was Bankunited, cutting an estimated $43.3M.
  • Alyeska Investment Group fully exited GE Aerospace in Q4 2015, selling an estimated $112M.
  • Alyeska Investment Group's ten largest holdings make up 12% of its $9.41B portfolio in Q4 2015.
  • Alyeska Investment Group opened 120 new positions and closed 208 in Q4 2015.
  • Alyeska Investment Group's portfolio value rose 10% quarter-over-quarter to $9.41B.

Based on Alyeska Investment Group's 13F filing for Q4 2015, filed 16 Feb 2016.